share_log

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Finn Jonathan

SEC announcement ·  Nov 15, 2023 16:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more